4.5 Review

Route of administration of attenuated sporozoites is instrumental in rendering immunity against Plasmodia infection

期刊

VACCINE
卷 34, 期 28, 页码 3229-3234

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2016.04.095

关键词

Radiation attenuated sporozoites (RAS); Circumsporozoite (CS) antigen; CDS+ T cells; Liver-stage (LS) antigen; Plasmodium berghei; Liver-stage malaria vaccine

资金

  1. DBT, Govt. of India, New Delhi [BT/PR3130/MED/12/519/2011]
  2. DST, Govt. of India, New Delhi [EMR/2014/000535]
  3. GSBTM, Govt. of Gujarat [GSBTM/MD/PROJECTS/SSA/2243]
  4. GUJCOST, Govt. of Gujarat [GUJCOST/MRP/2014-15/1629]
  5. UGC-RGNF
  6. NU Ph.D
  7. DST-Inspire fellowship

向作者/读者索取更多资源

Whole sporozoite vaccine (WSV) approach has been shown to induce efficient CDS+ T cell response, critical for developing of long-lasting sterile protection against Plasmodium. Although WSV was initiated over four decades ago, we still do not fully understand about the absolute requirements for the generation of liver-stage specific CD8(+) T memory cells. For more than a decade intravenous (IV) route of immunization has been shown to be protective in pre-clinical studies. However, the intradermal (ID) route is preferred over IV route by many researchers as it is perceived to mimic the natural route of parasite delivery through mosquito bite. Various clinical studies have shown that ID route provokes poor protective responses compared to those seen with IV route of administration. The present study highlights the importance of circumsporozoite (CS) protein in preventing sporozoite entry to the hepatocytes, which however, it is not necessarily sufficient to ensure sterile protection. Instead, this article favors the idea that liver-stage development is a prime requirement for generation of antigen specific CD8(+) T cells and suggests the conditions favored by IV inoculation of sporozoite. (C) 2016 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据